This inventor holds 1 USPTO granted patent. Top assignee: Mcgill University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Terence J Coderre: Innovator in Pharmaceutical Science
Introduction
Terence J Coderre is a notable inventor based in Dorval, Canada. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for pain management. His work has led to advancements that may improve the quality of life for many patients.
Latest Patents
Terence J Coderre holds a patent for "Pharmaceutical salts/co-crystals of pentoxifylline, clonidine and linsidomine with caffeic, protocatechuic or alpha-lipoic acid and use thereof for treatment of pain." This patent discloses pharmaceutical salts and co-crystals of pentoxifylline, clonidine, and linsidomine with caffeic acid, protocatechuic acid, or α-lipoic acid. The patent also details a method for preparing these compounds and describes topical compositions comprising said salts or co-crystals for treating pain.
Career Highlights
Terence J Coderre is affiliated with McGill University, where he continues to engage in research and development in the pharmaceutical sector. His work is characterized by a commitment to innovation and improving therapeutic options for patients suffering from pain.
Collaborations
Some of his notable coworkers include André Laferrière and Ghada Ayoub. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical field.
Conclusion
Terence J Coderre's contributions to pharmaceutical science, particularly in pain management, highlight his role as an innovator in the field. His patent and ongoing research at McGill University reflect his dedication to improving patient care through innovative solutions.